$BDRL
BLONDER TONGUE LABORATORIES INC

2013 Q2 Form 10-Q Financial Statement

#000114420413045508 Filed on August 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $7.146M $7.803M
YoY Change -8.42% 8.22%
Cost Of Revenue $4.694M $5.200M
YoY Change -9.73% 12.8%
Gross Profit $2.452M $2.603M
YoY Change -5.8% 0.5%
Gross Profit Margin 34.31% 33.36%
Selling, General & Admin $2.199M $2.172M
YoY Change 1.24% 23.41%
% of Gross Profit 89.68% 83.44%
Research & Development $836.0K $930.0K
YoY Change -10.11% 36.76%
% of Gross Profit 34.09% 35.73%
Depreciation & Amortization $320.0K $380.0K
YoY Change -15.79% 46.15%
% of Gross Profit 13.05% 14.6%
Operating Expenses $3.035M $3.102M
YoY Change -2.16% 27.13%
Operating Profit -$583.0K -$499.0K
YoY Change 16.83% -432.67%
Interest Expense $77.00K -$80.00K
YoY Change -196.25% 60.0%
% of Operating Profit
Other Income/Expense, Net -$77.00K -$84.00K
YoY Change -8.33%
Pretax Income -$660.0K -$583.0K
YoY Change 13.21% -630.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$660.0K -$583.0K
YoY Change 13.21% -630.0%
Net Earnings / Revenue -9.24% -7.47%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.11 -$0.09
COMMON SHARES
Basic Shares Outstanding 6.216M shares
Diluted Shares Outstanding 6.216M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.0K $210.0K
YoY Change -19.05% -85.62%
Cash & Equivalents $173.0K $211.0K
Short-Term Investments
Other Short-Term Assets $920.0K $1.290M
YoY Change -28.68% 26.47%
Inventory $10.50M $9.790M
Prepaid Expenses
Receivables $2.733M $4.830M
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.32M $16.12M
YoY Change -11.15% 12.02%
LONG-TERM ASSETS
Property, Plant & Equipment $3.853M $4.350M
YoY Change -11.43% 8.75%
Goodwill $493.0K
YoY Change
Intangibles $580.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $177.0K $7.550M
YoY Change -97.66% -6.21%
Total Long-Term Assets $9.836M $15.48M
YoY Change -36.46% 20.0%
TOTAL ASSETS
Total Short-Term Assets $14.32M $16.12M
Total Long-Term Assets $9.836M $15.48M
Total Assets $24.16M $31.60M
YoY Change -23.55% 15.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.320M $2.330M
YoY Change -43.35% 128.43%
Accrued Expenses $1.270M $1.580M
YoY Change -19.62% 49.06%
Deferred Revenue
YoY Change
Short-Term Debt $1.590M $3.850M
YoY Change -58.7%
Long-Term Debt Due $277.0K $270.0K
YoY Change 2.59% 3.85%
Total Short-Term Liabilities $4.484M $8.080M
YoY Change -44.5% 238.08%
LONG-TERM LIABILITIES
Long-Term Debt $4.025M $4.280M
YoY Change -5.96% 45.08%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.025M $4.280M
YoY Change -5.96% 45.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.484M $8.080M
Total Long-Term Liabilities $4.025M $4.280M
Total Liabilities $8.509M $12.36M
YoY Change -31.16% 131.03%
SHAREHOLDERS EQUITY
Retained Earnings -$1.514M
YoY Change
Common Stock $26.06M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.308M
YoY Change
Treasury Stock Shares 2.248M shares
Shareholders Equity $15.62M $19.25M
YoY Change
Total Liabilities & Shareholders Equity $24.16M $31.60M
YoY Change -23.55% 15.79%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$660.0K -$583.0K
YoY Change 13.21% -630.0%
Depreciation, Depletion And Amortization $320.0K $380.0K
YoY Change -15.79% 46.15%
Cash From Operating Activities $510.0K $60.00K
YoY Change 750.0% -84.62%
INVESTING ACTIVITIES
Capital Expenditures $190.0K $200.0K
YoY Change -5.0% -66.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$190.0K -$200.0K
YoY Change -5.0% -66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -220.0K 50.00K
YoY Change -540.0% -70.59%
NET CHANGE
Cash From Operating Activities 510.0K 60.00K
Cash From Investing Activities -190.0K -200.0K
Cash From Financing Activities -220.0K 50.00K
Net Change In Cash 100.0K -90.00K
YoY Change -211.11% 125.0%
FREE CASH FLOW
Cash From Operating Activities $510.0K $60.00K
Capital Expenditures $190.0K $200.0K
Free Cash Flow $320.0K -$140.0K
YoY Change -328.57% -33.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
196000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8465000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8465000 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2248000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2248000 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
453000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2733000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3461000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
10500000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
11319000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
916000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
723000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
14322000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
15956000 USD
CY2013Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
2390000 USD
CY2012Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2598000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3853000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4009000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001000683
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
BDR
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6215556 shares
dei Entity Registrant Name
EntityRegistrantName
BLONDER TONGUE LABORATORIES INC
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
552000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2343000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2470000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
493000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
493000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
177000 USD
us-gaap Selling Expense
SellingExpense
1711000 USD
us-gaap Gross Profit
GrossProfit
4514000 USD
CY2012Q2 us-gaap Selling Expense
SellingExpense
822000 USD
us-gaap Inventory Write Down
InventoryWriteDown
437000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-728000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-201000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1027000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-637000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
193000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
483000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-48000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
44000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-346000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
77000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4694000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13865000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
168000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5485000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4163000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
30000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
25918000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-372000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1621000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
7308000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
16625000 USD
bdr Percentage Of Fifo Inventory Non Current For Finished Goods
PercentageOfFifoInventoryNonCurrentForFinishedGoods
0.7 pure
CY2012 bdr Percentage Of Fifo Inventory Non Current For Finished Goods
PercentageOfFifoInventoryNonCurrentForFinishedGoods
0.64 pure
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7803000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5200000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1314000 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1350000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1691000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7146000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
3035000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
3102000 USD
us-gaap Operating Expenses
OperatingExpenses
5936000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-583000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-499000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-996000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-77000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-84000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-146000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-660000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-583000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1142000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9797000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
2603000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
2452000 USD
us-gaap Depreciation
Depreciation
233000 USD
us-gaap Depreciation
Depreciation
255000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
432000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
465000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
8925000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2947000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
930000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2534000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
836000 USD
CY2013Q2 us-gaap Selling Expense
SellingExpense
885000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
580000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
225000 USD
CY2013Q2 us-gaap Assets
Assets
24158000 USD
CY2012Q4 us-gaap Assets
Assets
26303000 USD
CY2013Q2 us-gaap Line Of Credit
LineOfCredit
1589000 USD
CY2012Q4 us-gaap Line Of Credit
LineOfCredit
2244000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
277000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
277000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1320000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1825000 USD
CY2013Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
459000 USD
CY2012Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
330000 USD
CY2013Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
617000 USD
CY2012Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
617000 USD
CY2013Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
24000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
24000 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
198000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4484000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4025000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
30000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
26054000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1514000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1621000 USD
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
7308000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
15619000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24158000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26303000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
14311000 USD
us-gaap Gross Profit
GrossProfit
4940000 USD
us-gaap Selling Expense
SellingExpense
1622000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1837000 USD
us-gaap Operating Expenses
OperatingExpenses
6406000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1892000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-171000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2063000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-2063000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6216000 shares
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
196000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
333000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
174000 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
7020000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-410000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7275000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
138000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
130000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-793000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5325000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-280000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-660000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-583000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1142000 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6216000 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6216000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6216000 shares
us-gaap Share Based Compensation
ShareBasedCompensation
136000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
105000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
923000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1310000 USD
bdr Business Acquisition Pro Forma Basic And Diluted Weighted Average Shares Outstanding
BusinessAcquisitionProFormaBasicAndDilutedWeightedAverageSharesOutstanding
6216000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1151000 shares
CY2012Q4 bdr Inventory Value Before Reserves
InventoryValueBeforeReserves
4783000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-640000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
851000 USD
CY2013Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
1589000 USD
us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-1661000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1873000 USD
CY2013Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
2376000 USD
bdr Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-0.30
CY2008 us-gaap Line Of Credit Facility Covenant Terms
LineOfCreditFacilityCovenantTerms
each expiring on February 1, 2015
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2015-02-01
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
15008000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
211000 USD
us-gaap Interest Paid
InterestPaid
139000 USD
us-gaap Interest Paid
InterestPaid
156000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-655000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
3854000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1601000 USD
us-gaap Business Acquisition Date Of Acquisition Agreement1
BusinessAcquisitionDateOfAcquisitionAgreement1
2012-02-01
bdr Business Acquisition Date Of Acquisition Agreement Amended
BusinessAcquisitionDateOfAcquisitionAgreementAmended
2012-02-03
CY2013Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1022000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1458000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1151000 shares
us-gaap Inventory Related Text
InventoryRelatedText
Inventories are stated at the lower of cost, determined by the first-in, first-out (FIFO) method, or market.
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
5371000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6493000 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2789000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2950000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6623000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6659000 USD
CY2013Q2 us-gaap Inventory Gross
InventoryGross
14783000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
16102000 USD
CY2013Q2 bdr Inventory Value Before Reserves
InventoryValueBeforeReserves
4283000 USD
CY2013Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
1893000 USD
CY2012Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2185000 USD
CY2008Q3 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
8000000 USD
CY2008 us-gaap Line Of Credit Facility Increase Decrease Other Net
LineOfCreditFacilityIncreaseDecreaseOtherNet
12850000 USD
CY2013Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0325 pure
CY2013Q2 bdr Line Of Credit Facility Interest Rate Period At One Month
LineOfCreditFacilityInterestRatePeriodAtOneMonth
0.0022 pure
CY2013Q2 bdr Line Of Credit Facility Interest Rate Period At Three Months
LineOfCreditFacilityInterestRatePeriodAtThreeMonths
0.0028 pure
CY2013Q2 bdr Line Of Credit Facility Interest Rate Period At Six Months
LineOfCreditFacilityInterestRatePeriodAtSixMonths
0.0042 pure
us-gaap Line Of Credit Facility Periodic Payment Principal
LineOfCreditFacilityPeriodicPaymentPrincipal
18000 USD

Files In Submission

Name View Source Status
0001144204-13-045508-index-headers.html Edgar Link pending
0001144204-13-045508-index.html Edgar Link pending
0001144204-13-045508.txt Edgar Link pending
0001144204-13-045508-xbrl.zip Edgar Link pending
bdr-20130630.xml Edgar Link completed
bdr-20130630.xsd Edgar Link pending
bdr-20130630_cal.xml Edgar Link unprocessable
bdr-20130630_def.xml Edgar Link unprocessable
bdr-20130630_lab.xml Edgar Link unprocessable
bdr-20130630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
v351690_10q.htm Edgar Link pending
v351690_ex10-1.htm Edgar Link pending
v351690_ex31-1.htm Edgar Link pending
v351690_ex31-2.htm Edgar Link pending
v351690_ex32-1.htm Edgar Link pending